SCHEMBL8022916

SCHEMBL8022916

[CH2]c1ccc(O)cc1CC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B3 P37058 1/20 0.43
GABRA1 P14867 1/20 0.41
GABRB2 P47870 1/20 0.41
TYR P14679 3/20 0.41
HSP90AB1 P08238 1/20 0.41
HSD17B1 P14061 1/20 0.40
ESR1 P03372 4/20 0.40
ESR2 Q92731 4/20 0.40
ESRRB O95718 1/20 0.40
ESRRA P11474 1/20 0.40
ANPEP P15144 1/20 0.40
DPP4 P27487 1/20 0.40
CYP3A4 P08684 2/20 0.38
TSHR P16473 2/20 0.38
MEN1 O00255 1/20 0.38
TP53 P04637 1/20 0.38
ALOX5 P09917 1/20 0.38
MAPT P10636 1/20 0.38
ALOX15 P16050 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6522032 0.85 TYR (0.46) HSD17B3TYRESR1ESR2CYP3A4
SCHEMBL6676642 0.81 TYR (0.61) TYRESR1ESR2CYP3A4TSHR
SCHEMBL3444233 0.81 TYR (0.39) TYRHSP90AB1ESR2TSHRALOX5
SCHEMBL1724358 0.80 TYR (0.48) HSD17B3GABRA1GABRB2TYRHSP90AB1
SCHEMBL30979257 0.80 TYR (0.48) HSD17B3GABRA1GABRB2TYRHSP90AB1
SCHEMBL11877971 0.79 ABAT (0.41) TYRCYP3A4TSHRMAPTKMT2A
SCHEMBL29531568 0.78 ANPEP (0.49) HSD17B3GABRA1GABRB2TYRHSP90AB1
SCHEMBL71448 0.78 ESR1 (0.57) TYRHSP90AB1HSD17B1ESR1ESR2
SCHEMBL29408416 0.78 ESR1 (0.57) TYRHSP90AB1HSD17B1ESR1ESR2
SCHEMBL7105504 0.78 ANPEP (0.49) HSD17B3GABRA1GABRB2TYRHSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1037630-A2 METHOD FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH APOPTOSIS USING N-HETEROCYCLIC GLYOXYLAMIDE COMPOUNDS SHIONOGI & CO., LTD. (JP) 2000-09-27 EP disclosed
EP-0977566-A1 METHOD FOR THE TREATMENT OF STROKE USING N-HETEROCYCLIC GLYOXYLAMIDE COMPOUNDS SHIONOGI & CO., LTD. (JP) 2000-02-09 EP disclosed
WO-1999024026-A2 METHOD FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH APOPTOSIS USING N-HETEROCYCLIC GLYOXYLAMIDE COMPOUNDS SHIONOGI & CO., LTD. (JP) 1999-05-20 WO disclosed
WO-1998047508-A1 METHOD FOR THE TREATMENT OF STROKE USING N-HETEROCYCLIC GLYOXYLAMIDE COMPOUNDS SHIONOGI & CO., LTD. (JP) 1998-10-29 WO disclosed